IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
IASLC Exclusive Webinar: Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic
April 29, 2020 | Online

Overview

IASLC faculty members from Europe, Asia, and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on 1) how COVID-19 impacts their patient population, 2) changes made in the management of current and newly diagnosed lung cancer patients due to pandemic, including starting and stopping treatment and monitoring, 3) testing for COVID-19, and 4) outcomes of COVID-19 positive lung cancer patients.

Date and Time: April 29, 2020 at 9:00AM EDT; 3:00PM CEST; 9:00PM HKT
Format: There will be two presentations followed by ample time for questions from the audience.

What you should expect to learn

At the conclusion of this webinar, learners will have improved their ability to make treatment decisions for patients with advanced stage lung cancer during the COVID-19 pandemic.

Medical oncologists treating lung cancer patients, other clinical specialists involved in lung cancer care, and patients/patients advocates.


SureshR.jpg   

Suresh S. Ramalingam, MD, FACP, FASCO (Moderator) 
Roberto C. Goizueta Chair for Cancer Research
Deputy Director, Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA.


FedericoCappuzzo.jpg 

Federico Cappuzzo, MD
Director of Oncology and Hematology Department
AUSL della Romagna-Ravenna


CaicunZ.jpg  

Caicun Zhou, MD, PhD
Department of Oncology, 
Shanghai Pulmonary Hospital, 
Affiliated to Tongji University School of Medicine, Shanghai, China

Disclosure:

No one involved in the planning or presentation of this activity has disclosed a relevant financial relationship.

Planning Chair:
Francisco Suarez, MD, Chile

Planning Committee Members:
Federico Cappuzzo, MD, Italy
Caicun Zhou, MD, PhD, China
Murry Wynes, PhD, United States
Chandra Belani, MD, United States
Kirsten Black, PhD, MPH, United States

Contact

IASLC CME Department

Overview

IASLC faculty members from Europe, Asia, and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on 1) how COVID-19 impacts their patient population, 2) changes made in the management of current and newly diagnosed lung cancer patients due to pandemic, including starting and stopping treatment and monitoring, 3) testing for COVID-19, and 4) outcomes of COVID-19 positive lung cancer patients.

Date and Time: April 29, 2020 at 9:00AM EDT; 3:00PM CEST; 9:00PM HKT
Format: There will be two presentations followed by ample time for questions from the audience.

What you should expect to learn

At the conclusion of this webinar, learners will have improved their ability to make treatment decisions for patients with advanced stage lung cancer during the COVID-19 pandemic.

Medical oncologists treating lung cancer patients, other clinical specialists involved in lung cancer care, and patients/patients advocates.


SureshR.jpg   

Suresh S. Ramalingam, MD, FACP, FASCO (Moderator) 
Roberto C. Goizueta Chair for Cancer Research
Deputy Director, Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA.


FedericoCappuzzo.jpg 

Federico Cappuzzo, MD
Director of Oncology and Hematology Department
AUSL della Romagna-Ravenna


CaicunZ.jpg  

Caicun Zhou, MD, PhD
Department of Oncology, 
Shanghai Pulmonary Hospital, 
Affiliated to Tongji University School of Medicine, Shanghai, China

Disclosure:

No one involved in the planning or presentation of this activity has disclosed a relevant financial relationship.

Planning Chair:
Francisco Suarez, MD, Chile

Planning Committee Members:
Federico Cappuzzo, MD, Italy
Caicun Zhou, MD, PhD, China
Murry Wynes, PhD, United States
Chandra Belani, MD, United States
Kirsten Black, PhD, MPH, United States

Contact

IASLC CME Department